Nuclear factor kappa-B and the heart
- PMID: 11499717
- DOI: 10.1016/s0735-1097(01)01377-8
Nuclear factor kappa-B and the heart
Abstract
Nuclear factor kappa-B (NFkappaB), a redox-sensitive transcription factor regulating a battery of inflammatory genes, has been indicated to play a role in the development of numerous pathological states. Activation of NFkappaB induces gene programs leading to transcription of factors that promote inflammation, such as leukocyte adhesion molecules, cytokines, and chemokines, although some few substances with possible anti-inflammatory effects are also NFkappaB regulated. The present article reviews basic regulation of NFkappaB and its activation, cell biological effects of NFkappaB activation and the role of NFkappaB in apoptosis. Evidence involving NFkappaB as a key factor in the pathophysiology of ischemia-reperfusion injury and heart failure is discussed. Although activation of NFkappaB induces pro-inflammatory genes, it has lately been indicated that the transcription factor is involved in the signaling of endogenous myocardial protection evoked by ischemic preconditioning. A possible role of NFkappaB in the development of atherosclerosis and unstable coronary syndromes is discussed. Nuclear factor kappa-B may be a new therapeutic target for myocardial protection.
Similar articles
-
Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure.Basic Res Cardiol. 2004 Jan;99(1):1-7. doi: 10.1007/s00395-003-0442-7. Epub 2003 Oct 30. Basic Res Cardiol. 2004. PMID: 14685699 Review.
-
Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart.Eur J Cardiothorac Surg. 2008 Nov;34(5):976-84. doi: 10.1016/j.ejcts.2008.07.066. Epub 2008 Oct 7. Eur J Cardiothorac Surg. 2008. PMID: 18842422 Clinical Trial.
-
Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.Eur J Cardiothorac Surg. 2004 Nov;26(5):968-73. doi: 10.1016/j.ejcts.2004.06.015. Eur J Cardiothorac Surg. 2004. PMID: 15519191
-
[Clinical value of some factors of gene transcription in heart diseases].Kardiologiia. 2004;44(1):66-70. Kardiologiia. 2004. PMID: 15029150 Review. Russian.
-
A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury.Circulation. 1997 Nov 4;96(9 Suppl):II-280-4; discussion II-285. Circulation. 1997. PMID: 9386111
Cited by
-
MiR-23a Is Involved in Myocardial Ischemia/Reperfusion Injury by Directly Targeting CX43 and Regulating Mitophagy.Inflammation. 2021 Aug;44(4):1581-1591. doi: 10.1007/s10753-021-01443-w. Epub 2021 Mar 2. Inflammation. 2021. PMID: 33651309
-
Conditional knockout of prolyl hydroxylase domain protein 2 attenuates high fat-diet-induced cardiac dysfunction in mice.PLoS One. 2014 Dec 29;9(12):e115974. doi: 10.1371/journal.pone.0115974. eCollection 2014. PLoS One. 2014. PMID: 25546437 Free PMC article.
-
Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results.Int J Mol Sci. 2021 Dec 2;22(23):13053. doi: 10.3390/ijms222313053. Int J Mol Sci. 2021. PMID: 34884857 Free PMC article. Review.
-
Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF-kappaB pathway.Int J Exp Pathol. 2009 Jun;90(3):355-64. doi: 10.1111/j.1365-2613.2009.00659.x. Int J Exp Pathol. 2009. PMID: 19563618 Free PMC article.
-
Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.J Mol Biol. 2008 Jan 18;375(3):637-49. doi: 10.1016/j.jmb.2007.10.006. Epub 2007 Oct 10. J Mol Biol. 2008. PMID: 18037434 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
